蛋白名稱:KDR人重組蛋白，10012-H02H
蛋白構建:A DNA sequence encoding the extracellular domain of human VEGFR2 (NP_002244.1) (Met 1-Glu 764) was fused with the Fc region of human IgG1 at the C-terminus.
表達宿主:HEK293 Cells
蛋白純度:> 90 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC.
蛋白活性:

1. Immobilized  Human VEGF121 (Cat:10008-HNAH) at 2 μg/mL (100 μL/well) can bind Human VEGFR2/KDR (ECD, hFc Tag)(Cat:10012-H02H), the EC50 of Human VEGFR2/KDR (ECD, hFc Tag)(Cat:10012-H02H) is 6-48 ng/mL. 

2. Measured by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 20-120 ng/mL in the presence of 10 ng/mL recombinant human VEGF165.

蛋白內毒素:< 1.0 EU per μg of the protein as determined by the LAL method
預測N端:Ala 20
蛋白分子量:The recombinant human VEGFR2/Fc is a disulfide-linked homodimeric protein. The reduced monomer consists of 979 amino acids and predicts a molecular mass of 109 kDa. The apparent molecular mass of human VEGFR2/Fc monomer is approximatly 150-160 KDa in SDS-PAGE under reducing conditions due to glycosylation.
蛋白NP號:NP_002244.1
蛋白氨基酸序列:Met1-Glu764
蛋白標簽:C-human IgG1-Fc

歡迎去義翹神州網查看KDR人重組蛋白詳細信息。

義翹神州業務布局

義翹神州總部位于中國北京，在上海、廣州設立了分公司，于美國、歐洲、日本、中國蘇州、中國泰州建立了子公司，并在擁有幾十家經銷商，致力于為客戶提供更加便捷、高效、優質、專業的服務。

我們的宗旨：

堅持自主開發，不斷提升技術水平，為生命科學研究和生物醫藥創新研發提供高質量試劑和服務支撐，助力推動健康事業發展，造福人類。

人才建設：

①人才隊伍：900+

②碩士及以上學歷人才：230+

我們的客戶

客戶涵蓋大學、科研院所、醫藥研發企業等國內外各類生物研發單位

硬件設施

①超過20,000平米的研發生產中心

②超過5,000平米的潔凈生產車間